Status:
NOT_YET_RECRUITING
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
Lead Sponsor:
Amplified Sciences Inc
Conditions:
Pancreatic Cystic Lesions
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoe...
Detailed Description
A prospective observational study to assess the impact of PanCystPro in patients with radiographically confirmed pancreatic cysts planned for Endoscopic Ultra Sound (EUS) Fine Needle Aspirate (FNA). E...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Cross sectional imaging studies demonstrating a pancreatic cyst at least 12 mm in size where fluid sampling can aid in patient's management
- Written informed consent.
- The patient will be undergoing EUS with anticipated FNA extraction as part of standard patient care.
Exclusion
- Patients diagnosed with pancreatic cancer.
- Pregnant or lactating females.
- Patients with contraindications to moderate or deep procedural sedation (necessary for the conduct of the endoscopic ultrasound) like major cardiorespiratory illness.
- Patients with contraindications to FNA of a pancreatic cyst like being on blood thinners.
Key Trial Info
Start Date :
December 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 16 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06894329
Start Date
December 15 2025
End Date
March 16 2027
Last Update
September 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.